Quantcast
Home > Quotes > TOCA

Tocagen Inc. Common Stock (TOCA) Quote & Summary Data

TOCA 
$9.4
*  
0.36
3.98%
Get TOCA Alerts
*Delayed - data as of Jun. 19, 2018  -  Find a broker to begin trading TOCA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    TOCA Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
14.75
Today's High / Low
$ 9.50 / $ 8.98
Share Volume
104,031
50 Day Avg. Daily Volume
105,652
Previous Close
$ 9.04
52 Week High / Low
$ 15.46 / $ 8.60
Market Cap
187,182,040
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -2.26
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.68

Intraday Chart

Shares Traded

Share Volume:
104,031
50 Day Avg. Daily Volume:
105,652

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.26

Trading Range

The current last sale of $9.40 is 9.30% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 9.50 $ 15.46
 Low: $ 8.98 $ 8.60

Company Description (as filed with the SEC)

We are a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly-applicable product candidates designed to activate a patient's immune system against their own cancer from within. Our cancer-selective gene therapy platform is built on retroviral replicating vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Our gene therapy approach is designed to fight cancer through immunotherapeutic mechanisms of action without the autoimmune toxicities commonly experienced with other immunotherapies. Our founding vision is "No One Should Die Of Cancer" because we believe the immune system can be safely activated to fight the patient's cancer.  ... More ...  

Risk Grade

Where does TOCA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.99
Open Date:
Jun. 19, 2018
Close Price:
$ 9.04
Close Date:
Jun. 19, 2018

Consensus Recommendation

Analyst Info